Back to Search
DR. KRISTI JO MCINTYRE MD
MD
Medical Oncology Physician
NPI: 1912949033IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
H9380(TX)
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 1982
Research & Publications (20)
The impact of sheep breed on the risk of classical scrapie.
PMID 19678970·Epidemiol Infect·2010
7-preclinical
Cognitive dysfunction after experimental febrile seizures.
PMID 19000675·Exp Neurol·2009
7-preclinical
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
PMID 19652024·J Pharmacol Exp Ther·2009
7-preclinical
Prevalence of sheep infected with classical scrapie in Great Britain, 1993-2007.
PMID 19351431·Epidemiol Infect·2009
7-preclinical
Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium).
PMID 19085814·Planta Med·2009
7-preclinical
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
PMID 19459042·Breast Cancer Res Treat·2009
3-trial
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
PMID 19376699·Bioorg Med Chem Lett·2009
7-preclinical
Collaborative approach in assessing community readiness for a pandemic event.
PMID 19643280·Am J Infect Control·2009
8-other
A structured light-based system for scanning subcutaneous tumors in laboratory animals.
PMID 18589868·Comp Med·2008
7-preclinical
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
PMID 18364256·Bioorg Med Chem Lett·2008
7-preclinical
No temporal trends in the prevalence of atypical scrapie in British sheep, 2002-2006.
PMID 18384678·BMC Vet Res·2008
7-preclinical
Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
PMID 18072718·J Med Chem·2008
7-preclinical
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor.
PMID 18313298·Bioorg Med Chem Lett·2008
7-preclinical
Epidemiological characteristics of classical scrapie outbreaks in 30 sheep flocks in the United Kingdom.
PMID 19098982·PLoS One·2008
7-preclinical
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
PMID 18359226·Bioorg Med Chem Lett·2008
8-other
Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat.
PMID 18692968·Psychoneuroendocrinology·2008
7-preclinical
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
PMID 17540562·Bioorg Med Chem Lett·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8220 WALNUT HILL LN, SUITE 700
DALLAS, TX 75231 - Phone
- (214) 739-4175
Quick Facts
- NPI
- 1912949033
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile